The new molecule – called DSP-0038 – is being developed by Japan's Sumitomo Dainippon Pharma (DSP), which is now starting a phase 1 trial in the US as a treatment for psychosis associated with ...

Dainippon Sumitomo Pharma (DSP), and Evotec. Those deals had already made Exscientia one of the most well-funded players in the AI drug discovery category even before it closed a $510 million ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Professor of Psychiatry and Molecular Medicine, Department of Psychiatry; Hofstra North Shore Long Island School of Medicine, Hempstead, New York; Medical Director, Recognition and Prevention ...

Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Forbes does not accept payment for placement on lists.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

2914.T Japan Tobacco Inc.

Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15–25% of the ...